PyInvesting

Market research

FUP.F Fuji Pharma Co., Ltd

F EUR Healthcare

Latest close

9.90 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
272M
P/E ratio
17.05
Analyst target
Not available
Dividend yield
0.0%
Beta
0.34

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Fuji Pharma Co., Ltd is currently in a long term uptrend where the price is trading 6.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.

Fuji Pharma Co., Ltd's total revenue rose by 3.6% to $9B since the same quarter in the previous year.

Its net income has increased by 78.3% to $1B since the same quarter in the previous year.

Based on the above factors, Fuji Pharma Co., Ltd gets an overall score of 4/5.